Evidence map›Paper›PMID 42154407›Full record

ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2026

Trends in the Management of Keratoconus in Australia.

Richard Kha, Himal Kandel, Stephanie Watson

Abstract read
In one paragraph

Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Richard KhaSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Himal KandelSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Stephanie WatsonSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. stephanie.watson@sydney.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOver the past few decades, management options for keratoconus have evolved to include corneal crosslinking (CXL), keratoplasty and advanced contact lenses. This study aimed to describe trends in the use of various keratoconus management techniques in Australia.

methodsThis cross-sectional study extracted data on the use of keratoconus management techniques in Australia from various data sources. Corneal graft and national CXL data were obtained from the Australian Corneal Graft Registry, Medicare Benefits Schedule and Save Sight Keratoconus Registry. Data on the number and proportion of rigid gas permeable (RGP) and scleral contact lenses were collected from the International Contact Lens Prescribing Survey and contact lens manufacturers. The number of RGP and scleral contact lenses, keratoplasty and CXL used for managing keratoconus in Australia were analysed.

resultsCorneal grafts for keratoconus decreased from 3170 in 2001-2010 to 2797 in 2011-2020. This coincided with increased use of CXL, as well as RGP and scleral contact lens use. Since 2007, the proportion of RGP lenses sold in Australia has increased from 5% to 18% of all lenses. Over the past three decades, the estimated number of RGP and scleral lenses sold for the treatment of keratoconus has doubled. CXL use has increased and was more common in males and patients aged 15-24 years, with variability in corneal CXL rates across each state.

conclusionsIn Australia, there is a decreasing trend in keratoplasty for keratoconus along with increases in CXL and contact lens use. Future studies should evaluate outcomes associated with the change in keratoconus management patterns.

Indexed as

Contact LensesCorneal Cross-LinkingCorneal TransplantationCross-Linking ReagentsDisease ManagementKeratoconusAdultAustraliaCross-Sectional StudiesFemaleHumansMalePhotosensitizing AgentsCross-Linking ReagentsPhotosensitizing AgentsAustraliaContact lensesCorneal transplantCrosslinkingKeratoconusKeratoplasty

Identifiers

PMID42154407
PMCPMC13368842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.